Protocol for a parallel group, two-arm, superiority cluster randomised trial to evaluate a community-level complementary-food safety and hygiene and nutrition intervention in Mali: the MaaCiwara study (version 1.3; 10 November 2022)
ConclusionsThe trial will provide evidence on the effectiveness of community-based behavioural change interventions designed to reduce the burden of diarrhoeal disease in the under-fives and how effectiveness varies across different contexts.Trial registrationISRCTN14390796. Registration date December 13, 2021 (Source: Trials)
Source: Trials - January 30, 2023 Category: Research Source Type: clinical trials
Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1 –11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial
DiscussionIf LAKANA provides evidence in support of a positive mortality benefit resulting from azithromycin MDA, it will significantly contribute to the options for successfully promoting child survival in Mali, and elsewhere in sub-Saharan Africa.Trial registrationClinicalTrials.gov NCT04424511. Registered on 11 June 2020. (Source: Trials)
Source: Trials - January 3, 2023 Category: Research Source Type: clinical trials
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
Condition: Malaria Interventions: Biological: PfSPZ Vaccine; Other: PfSPZ Diluent; Drug: Normal Saline Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Phase 1 Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
Condition: Malaria Interventions: Biological: PfSPZ Vaccine; Other: PfSPZ Diluent; Drug: Normal Saline Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
Condition: Malaria Interventions: Biological: PfSPZ Vaccine; Other: PfSPZ Diluent; Drug: Normal Saline Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
